Twin Health, makers of the Whole Body Digital Twin, precision health technology, has announced $140 million (INR 1000 Cr) in Series C funding after it scales its presence in India and the U.S.
The Series C funding round includes Sequoia Capital India, ICONIQ Capital, Perceptive Advisors, Corner Ventures, LTS Investments, Helena and Sofina to help the company service and help solve the chronic metabolic disease health crisis.
Founded in 2018, the company launched Whole Body Digital Twin to help reverse and prevent chronic metabolic diseases, while improving energy and physical health. Powered by artificial intelligence, it represents each individual’s unique metabolism, built from thousands of data points collected daily via wearable sensors and self-reported preferences.
It also provides guidance for nutrition, sleep, activity and meditative breathing to patients and their doctors to safely reverse and prevent a variety of chronic metabolic diseases, including type 2 diabetes, cardiovascular disease and liver disease.
“We are each gifted a body. If given a chance, it can heal itself. Our Whole Body Digital Twin lives alongside you – giving you a simple, clear view into your beautifully complex biology, continuously learning about your metabolism and telling you what you can do to improve your health in the moment,” Jahangir Mohammed, Founder and CEO, Twin Health, said.
Chronic metabolic diseases like type 2 diabetes can start as an individual’s metabolism breaks down over time. Medical research has demonstrated that each person’s metabolism functions differently, presenting significant challenges to customize treatment for every single person.